Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients | Zendy

Tatjana Marković | Zendy; Ljiljana Jeinić | Zendy; Aleksandra Šmitran | Zendy; Miroslav Petković | Zendy

Open Access

Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients

Author(s) -

Tatjana Marković,

Ljiljana Jeinić,

Aleksandra Šmitran,

Miroslav Petković

Publication year - 2013

Publication title -

srpski arhiv za celokupno lekarstvo

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.135

H-Index - 17

eISSN - 2406-0895

pISSN - 0370-8179

DOI - 10.2298/sarh1312775m

Subject(s) - cefepime , cefotaxime , imipenem , microbiology and biotechnology , piperacillin , ampicillin , medicine , amikacin , ceftazidime , beta lactamase , antimicrobial , gentamicin , cefazolin , antibiotic resistance , amoxicillin , drug resistance , escherichia coli , antibiotics , biology , bacteria , pseudomonas aeruginosa , biochemistry , genetics , gene

In Gram-negative bacteria, the production of beta-lactamases is the most important mechanism of resistance to beta-lactam antibiotics. In the Banja Luka region, there were no extensive researches on the prevalence and antimicrobial resistance of the extended-spectrum beta-lactamase (ESBL) producing Escherichia coli (E. coli) isolates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research